Lowe Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

Lowe Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$353	Hold	40	–	–	﹤0.01%	382
2025 Q2	$255	Hold	40	–	–	﹤0.01%	353
2025 Q1	$194	Hold	40	–	–	﹤0.01%	364
2024 Q4	$382	Hold	40	–	–	﹤0.01%	346
2024 Q3	$334	Hold	40	–	–	﹤0.01%	304
2024 Q2	$273	Hold	40	–	–	﹤0.01%	305
2024 Q1	$101	Hold	40	–	–	﹤0.01%	305
2023 Q4	$96	Hold	40	–	–	﹤0.01%	313
2023 Q3	$136	Hold	40	–	–	﹤0.01%	302
2023 Q2	$294	Hold	40	–	–	﹤0.01%	341
2023 Q1	$414	Hold	40	–	–	﹤0.01%	334
2022 Q4	$472	Sell	40 -40	-50%	-$619	﹤0.01%	335
2022 Q3	$2K	Hold	80	–	–	﹤0.01%	292
2022 Q2	$2K	Hold	80	–	–	﹤0.01%	273
2022 Q1	$3K	Hold	80	–	–	﹤0.01%	268
2021 Q4	$3K	Buy	+80	New	+$3.62K	﹤0.01%	251

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Lowe Wealth Advisors's EBS Position: Q3 2025 in Review

Lowe Wealth Advisors held its Emergent Biosolutions (EBS) position steady in Q3 2025 at 40 shares worth $353. The position accounts for ﹤0.01% of the portfolio, ranked #382.

Lowe Wealth Advisors first reported a position in EBS in Q4 2021 and has held it in 16 quarters since. The position peaked at $3K in Q1 2022. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

Lowe Wealth Advisors held 40 shares of Emergent Biosolutions worth $353 as of Q3 2025.
Lowe Wealth Advisors left its Emergent Biosolutions share count unchanged in Q3 2025.
Emergent Biosolutions made up ﹤0.01% of Lowe Wealth Advisors's portfolio in Q3 2025, its #382 holding.
Lowe Wealth Advisors first reported a position in Emergent Biosolutions in Q4 2021 and has held it in 16 quarters since.
Lowe Wealth Advisors's Emergent Biosolutions position peaked at $3K in Q1 2022.
169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.